Alexander W Clowes Selected Research

Alexander W Clowes Research Topics

Disease

10	Hyperplasia 02/2016 - 08/2002
8	Pathologic Constriction (Stenosis) 01/2016 - 07/2004
8	Atrophy 07/2011 - 03/2002
7	Neointima 07/2011 - 03/2002
4	Vascular System Injuries 02/2016 - 03/2002
4	Inflammation (Inflammations) 08/2015 - 11/2011
3	Obesity 08/2015 - 12/2011
3	Insulin Resistance 08/2015 - 06/2013
3	Chronic Limb-Threatening Ischemia 12/2007 - 01/2005
2	Thrombosis (Thrombus) 02/2016 - 11/2006
2	Stroke (Strokes) 10/2013 - 09/2006
2	Atherosclerosis 07/2004 - 08/2002
1	Myocardial Infarction 10/2013
1	Wounds and Injuries (Trauma) 12/2007
1	Pain (Aches) 11/2006
1	Hypertension (High Blood Pressure) 11/2006
1	Wound Infection (Wound Infections) 11/2006
1	Infections 09/2006
1	Arteriovenous Fistula 01/2006
1	Peripheral Arterial Disease 01/2005
1	Peripheral Arterial Occlusive Disease 1 01/2005
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2003
1	Rupture 01/2003
1	Unstable Angina 01/2003
1	Aneurysm (Aneurysms) 01/2003

Drug/Important Bio-Agent (IBA)

6	Polytetrafluoroethylene (Teflon)FDA Link 07/2011 - 03/2002
5	Phenobarbital (Luminal)FDA Link 02/2016 - 12/2002
5	Versicans (Versican)IBA 09/2009 - 03/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 07/2004
3	Platelet-Derived Growth FactorIBA 03/2008 - 08/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 05/2009
2	vasodilator-stimulated phosphoproteinIBA 10/2014 - 11/2011
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2011 - 11/2011
2	Fas Ligand Protein (Fas Ligand)IBA 07/2011 - 09/2009
2	Becaplermin (PDGF-BB)FDA Link 05/2009 - 08/2002
2	BiglycanIBA 12/2008 - 01/2005
2	TropoelastinIBA 12/2008 - 03/2002
2	Biological ProductsIBA 05/2008 - 01/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2008 - 02/2004
2	AntibodiesIBA 03/2008 - 02/2004
2	edifoligideIBA 04/2006 - 01/2005
2	CollagenIBA 01/2005 - 03/2002
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 06/2004 - 01/2003
1	Proteins (Proteins, Gene)FDA Link 02/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2015
1	Insulin (Novolin)FDA Link 10/2014
1	PalmitatesIBA 10/2014
1	EpitopesIBA 10/2013
1	Immunoglobulin M (IgM)IBA 10/2013
1	AMP-Activated Protein KinasesIBA 06/2013
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2011
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 07/2011
1	Syndecan-1 (Syndecan 1)IBA 09/2009
1	Messenger RNA (mRNA)IBA 09/2009
1	Thrombin FDA Link 05/2009
1	Heparin (Liquaemin)FDA LinkGeneric 05/2009
1	GlycosaminoglycansIBA 12/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2008
1	AnticoagulantsIBA 12/2007
1	Polyethylene Terephthalates (Polyethylene Terephthalate)IBA 09/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2006
1	Bone Morphogenetic Protein 4IBA 01/2006
1	Hyaluronic Acid (Hyaluronan)IBA 01/2005
1	Proteoglycans (Proteoglycan)IBA 01/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2004
1	ProstaglandinsIBA 07/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2004
1	Cyclooxygenase 1IBA 07/2004
1	Bromodeoxyuridine (BrdU)IBA 03/2003
1	Immunoglobulin G (IgG)IBA 03/2003
1	ErbB Receptors (EGF Receptor)IBA 03/2003
1	Pharmaceutical PreparationsIBA 01/2003
1	Monoclonal AntibodiesIBA 01/2003
1	CDP860IBA 01/2003
1	InterleukinsIBA 08/2002
1	Serine Proteases (Serine Protease)IBA 03/2002
1	Fibrinolysin FDA Link 03/2002
1	Peptide Hydrolases (Proteases)FDA Link 03/2002

Therapy/Procedure

2	Transplantation 08/2015 - 01/2003
2	Surgical Amputation (Amputations) 11/2006 - 04/2006
2	Length of Stay 11/2006 - 01/2003
2	Therapeutics 04/2006 - 01/2005
2	Stents 03/2005 - 01/2003
2	Catheters 07/2004 - 03/2003
1	Fat-Restricted Diet (Diet, Fat Restricted) 10/2014
1	Limb Salvage 11/2006
1	Patient Readmission 11/2006
1	Carotid Endarterectomy 09/2006
1	Endarterectomy (Thromboendarterectomy) 09/2006
1	Intravenous Administration 01/2003